Quick View
| Metric | Current Period | Same Period Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥236.2B | ¥225.2B | +4.9% |
| Operating Income | ¥32.9B | ¥30.4B | +8.2% |
| Ordinary Income | ¥35.2B | ¥32.0B | +10.2% |
| Net Income | ¥23.6B | ¥20.4B | +15.8% |
| ROE | 4.1% | 3.6% | - |
Executive Summary
Cumulative results for FY2026 Q3 showed increases in both revenue and earnings, demonstrating a favorable business mix in which earnings growth outpaced revenue growth. Revenue was ¥236.2B (+4.9% YoY), Operating Income was ¥32.9B (+8.2%), Ordinary Income was ¥35.2B (+10.2%), and Net Income attributable to owners of the parent was ¥23.6B (+15.8%). Earnings growth was driven by profit expansion in the Porous Materials Business and improved profitability in the Services Business, while the Fine Chemicals Business recorded lower earnings, indicating differences in the quality of growth across businesses.
Factors Affecting Performance
【Revenue】Revenue was ¥236.2B, an increase of +4.9% YoY. By segment, Porous Materials recorded ¥75.3B (31.9% composition ratio, +10.7% YoY), Fine Chemicals recorded ¥108.6B (45.9%, +2.4%), Services recorded ¥43.5B (18.4%, +1.9%), and Real Estate-related recorded ¥10.9B (4.6%). Growth in Porous Materials drove overall Company growth.
【Profit and Loss】Operating Income was ¥32.9B (+8.2% YoY), and the Operating Income margin improved from the previous year to 13.9%. Ordinary Income was ¥35.2B (+10.2%), with the ¥2.4B difference from Operating Income attributable to non-operating income, including ¥1.3B in dividend income received. Net Income was ¥23.6B (+15.8%); however, extraordinary income of ¥2.0B (including a ¥1.9B gain on the sale of investment securities) and extraordinary losses of ¥2.9B offset each other, resulting in net extraordinary losses reducing Net Income by approximately ¥0.9B. Both revenue and earnings increased.
Segment Analysis
Porous Materials recorded revenue of ¥75.3B (+10.7% YoY), Operating Income of ¥14.8B (+34.8%), and a margin of 19.7% (16.2% in the previous year), making it the strongest segment in both profitability and growth and the core business accounting for 45.1% of total Company earnings. Services recorded profit of ¥2.9B (+42.1%) on revenue of ¥43.5B (+1.9%), indicating a significant improvement in profitability, although its margin remained low at 6.7%. Fine Chemicals had the largest revenue scale at ¥108.6B (+2.4%), but Operating Income declined to ¥13.0B (-14.3%), with raw material costs and product mix profitability representing challenges. Real Estate-related recorded revenue of ¥10.9B, profit of ¥2.1B, and the highest margin at 21.9%, although its scale was limited. Growth in Porous Materials and Services offset the earnings decline in Fine Chemicals.
Key Financial Indicators
【Profitability】The Operating Income margin of 13.9% and Net Income margin of 10.0% were both at favorable levels. Operating leverage enabled earnings growth of +8.2%, exceeding revenue growth of +4.9%. 【Cash Flow Quality】Operating Cash Flow (OCF) was ¥15.5B, only 0.66 times Net Income of ¥23.6B, while the cash conversion ratio (OCF/EBITDA) was also low at 0.38 times, indicating relatively weak cash support for reported earnings. The primary factor was ¥12.6B in funds tied up due to an increase in trade receivables. 【Investment Efficiency】ROE was 4.1% (under DuPont decomposition: Net Income margin of 10.0% × total asset turnover of 0.36 times × financial leverage of 1.14 times), with the low total asset turnover serving as a constraint. Capital expenditures of ¥14.9B were 1.83 times depreciation and amortization of ¥8.1B, leaving post-investment free cash flow at only ¥2.2B. 【Financial Soundness】The Equity Ratio was 88.0%, while the current ratio was approximately 759%, calculated as current assets of ¥331.5B/current liabilities of ¥43.7B, an extremely high level. The debt-to-equity ratio was 0.14 times, reflecting a conservative capital structure.
Cash Flow Analysis
Operating Cash Flow was ¥15.5B, down -27.2% YoY, and represented only 0.66 times Net Income of ¥23.6B. The primary factor was a cash outflow resulting from a ¥12.6B increase in trade receivables, while ¥13.6B in income taxes paid also weighed on cash flow. Investing Cash Flow represented a net outflow of ¥13.3B, most of which consisted of capital expenditures of ¥14.9B, an investment scale 1.83 times depreciation and amortization of ¥8.1B. As a result, free cash flow (OCF + investing cash flow) was limited to ¥2.2B, indicating weaker cash generation compared with accounting earnings. Financing Cash Flow represented a net outflow of ¥11.1B, primarily due to dividend payments of ¥9.7B and share repurchases of ¥0.7B. Cash and cash equivalents declined from the end of the previous year, making the fact that internally generated cash is not sufficient to fully cover investment and dividends a monitoring point.
Earnings Quality
The impact of extraordinary gains and losses was limited relative to recurring operating earnings, but had a negative net effect. Of the ¥2.0B in extraordinary income, ¥1.9B was attributable to gains on the sale of investment securities, which were non-recurring rather than recurring income generated by business activities. Extraordinary losses of ¥2.9B were primarily related to losses on the disposal of fixed assets and other items, resulting in a net extraordinary loss of approximately ¥0.9B that reduced Net Income. Non-operating income of ¥2.4B consisted primarily of ¥1.3B in dividend income received, representing approximately 0.6% of revenue and indicating limited reliance. From an accrual perspective (the divergence between accounting profit and cash), OCF of ¥15.5B was below Net Income of ¥23.6B, primarily due to the increase in trade receivables. The Net Income growth rate of +15.8% includes gains on the sale of investment securities; accordingly, recurring business growth appears somewhat overstated and warrants attention.
Earnings Forecast and Guidance
The cumulative progress rates through Q3 against the Company’s full-year forecast were 76.7% for Revenue, 80.2% for Operating Income, 81.0% for Ordinary Income, and 84.2% for Net Income. At the point when 75% of the fiscal year had elapsed, all metrics exceeded the standard progress rate of 75%, with Net Income showing particularly strong progress. Operating Income required in Q4 is approximately ¥8.1B, calculated by subtracting cumulative Operating Income of ¥32.9B from the full-year forecast of ¥41.0B. If results remain at the previous year’s level, significant upside or downside risk to achieving the forecast appears limited. However, extraordinary income, including gains on the sale of investment securities, contributed to Net Income progress; therefore, full-year progress on a recurring business earnings basis should be assessed using Operating Income and Ordinary Income.
Shareholder Returns
The Q2 dividend was ¥23.50 per share, with an interim Payout Ratio of approximately 22.2% (dividends alone divided by Net Income). The full-year dividend forecast is ¥47.00 per share, resulting in a forecast full-year Payout Ratio of approximately 37.4% based on forecast full-year Net Income of ¥28.0B. This is below 60%, indicating high sustainability from an earnings perspective. Share repurchases of ¥0.7B were conducted as an additional form of shareholder return separate from dividends. Given cash and deposits of ¥213.7B and the low level of debt, short-term dividend payment capacity is high. However, coverage of dividend and investment funding requirements by free cash flow of ¥2.2B is limited, so cash-based capacity for shareholder returns should be viewed more cautiously than earnings-based capacity.
Risk Factors
-
Risk of deterioration in the profitability of the core segment: Fine Chemicals recorded Operating Income of -14.3% against revenue growth of +2.4%, as changes in raw material prices and product mix pressured earnings. Since this business accounts for 45.9% of total Company revenue, delays in profitability recovery could have a significant impact on overall Company performance.
-
Low cash conversion efficiency: OCF/Net Income was 0.66 times and OCF/EBITDA was 0.38 times, both low levels, primarily due to the ¥12.6B increase in trade receivables. Even if earnings growth continues, an elongated collection cycle could constrain capital efficiency.
-
Market volatility risk related to investment securities: Investment securities amounted to ¥80.5B, representing 12.2% of total assets, and a ¥1.9B gain on sale contributed to Net Income in the current period. Going forward, market price fluctuations could affect comprehensive income and net assets, as well as change the degree of reliance on gains from sales.
Industry Benchmark (For Reference; Compiled by the Company)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Income Margin | 13.9% | 8.6% (4.3%–12.7%) | +5.3pt |
| Net Income Margin | 10.0% | 6.4% (2.8%–10.3%) | +3.6pt |
Both the Operating Income margin and Net Income margin were significantly above the industry median, placing the Company’s profitability in the upper tier of the industry.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 4.9% | 3.3% (-2.1%–8.9%) | +1.6pt |
The Revenue growth rate also exceeded the industry median, placing the Company’s growth somewhat above the industry average.
※Source: Compiled by the Company
Key Points from the Financial Results
-
Porous Materials has become the core growth business, with a profit margin of 19.7% (improved from 16.2% in the previous year) and accounting for 45.1% of total Company earnings. A structural characteristic is that the center of gravity of the business portfolio is shifting toward this segment.
-
The Operating Income margin of 13.9% and Net Income margin of 10.0% are favorable, but ROE is only 4.1%, highlighting low asset efficiency. The substantial asset base, including cash of ¥213.7B and investment securities of ¥80.5B, is diluting profitability.
-
Full-year progress is ahead of the standard pace on an earnings basis, but OCF remains at only 0.66 times Net Income. Accordingly, assessing the quality of earnings growth will require monitoring future trade receivables collection and trends in cash conversion efficiency.
This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly available earnings data. Investment decisions should be made at your own responsibility, and you should consult a professional as necessary.
---End of Report---
AI Financial Analysis
Executive Summary
FY2026 Q3 cumulative performance was solid, with profit growth outpacing sales growth and operating-margin expansion, although cash conversion weakened materially. Revenue increased 4.9% YoY to ¥23.62bn. Operating income rose 8.2% to ¥3.29bn. Ordinary income increased 10.2% to ¥3.53bn. Net income attributable to owners grew 15.8% to ¥2.36bn. Gross margin improved by 58bp YoY to 38.4%, reflecting a favorable gross-profit increase relative to sales. Operating margin expanded by 43bp to 13.9%, placing profitability within the good range but below the 15% excellent benchmark. Net margin expanded by 94bp to 10.0%, reaching the excellent benchmark threshold. The improvement from operating income to ordinary income was aided by ¥236m of non-operating income, including ¥130m of dividend income and ¥61m of interest income. Net income also benefited from a net extraordinary loss of only ¥86m, comprising ¥204m of extraordinary income, principally a ¥189m gain on sales of investment securities, versus ¥289m of extraordinary losses. The porous-material segment was the principal earnings engine, with segment profit up 34.8% YoY to ¥1.48bn. Conversely, fine chemical segment profit declined 14.3% despite revenue growth, limiting the consolidated operating-margin uplift. Operating cash flow of ¥1.55bn was below net income of ¥2.36bn, producing an OCF/net-income ratio of 0.66x and indicating that reported earnings were not fully converted into cash during the period. Cash conversion of 0.38x of EBITDA is also weak, principally consistent with the ¥1.26bn increase in trade receivables reflected in operating cash flow. Free cash flow remained positive at ¥225m after elevated ¥1.49bn capital expenditure, but it provides limited near-term self-funding headroom for shareholder returns. The balance sheet remains exceptionally conservative, with ¥21.37bn of cash and deposits, a 759.1% current ratio, and D/E of only 0.14x. Q3 revenue progress is 76.7% of the FY forecast and operating-income progress is 80.2%, both broadly ahead of the standard 75% seasonal benchmark. Management's full-year forecast therefore appears achievable on the reported cumulative run rate, although fourth-quarter cash collection and the recovery of fine-chemical profitability are central to the quality of that outcome.
Profitability Analysis
The reported annualized ROE is 5.4%, decomposed under the three-factor DuPont framework into a 10.0% net profit margin, 0.476x asset turnover, and 1.14x financial leverage. The modest ROE is primarily a consequence of low asset turnover and deliberately conservative leverage rather than weak margins. Financial leverage is low because equity of ¥58.19bn funds 88.0% of total assets, while liabilities are only 12.0% of assets. The annualized 10.0% net margin is strong and improved from approximately 9.0% in the prior-year period. Gross margin rose from approximately 37.8% to 38.4%, a 58bp expansion. Operating margin improved from approximately 13.5% to 13.9%, a 43bp expansion, as gross profit grew 6.5%, ahead of the 5.5% increase in SG&A expenses. This positive operating leverage is constructive, though the SG&A increase was still slightly faster than revenue growth of 4.9%. The largest segment-level earnings change was porous materials, where segment profit increased ¥383m to ¥1.48bn and margin rose to 19.7% from 16.2%. Porous materials is the core business by operating-income contribution, generating 45.0% of aggregate segment profit. Fine chemicals remained the largest sales segment at ¥10.81bn, but its segment profit declined ¥217m to ¥1.30bn and its margin compressed to 12.0% from 14.4%. Services improved segment margin to 6.7% from 4.8%, with profit rising 42.1% to ¥290m. Real-estate-related operations retained the highest segment margin at 21.4%, though profit was broadly flat at ¥209m. The five-factor analysis shows a 68.5% tax burden and a 1.046x interest burden; the latter reflects net non-operating income rather than a debt-service burden. EBITDA was ¥4.10bn and the EBITDA margin was 17.4%, supporting the view that underlying operating profitability is healthy. As a JGAAP reporter, the company would amortize goodwill if it had material goodwill; however, reported intangible assets are only 1.3% of assets and there is no indication of a material goodwill-related distortion to EBITDA or net income.
Growth Assessment
Revenue growth of 4.9% was broad-based across all four reported segments. Fine chemicals grew 2.4% YoY to ¥10.81bn. Porous materials grew 10.7% to ¥7.50bn and provided the principal source of consolidated profit growth. Services increased 1.9% to ¥4.34bn. Real-estate-related revenue increased 3.5% to ¥975m. The revenue mix is therefore becoming more favorable to porous materials, whose 19.7% segment margin substantially exceeds the consolidated operating margin. Fine chemicals' margin decline is the principal operating issue because it remains the largest revenue contributor. The gap between ordinary-income growth of 10.2% and operating-income growth of 8.2% indicates that investment income made a modest additional contribution to earnings growth. Net income growth of 15.8% exceeded ordinary-income growth, supported in part by the gain on sales of investment securities. Consequently, the net-income growth rate should not be treated as entirely recurring operating growth. Against FY guidance, Q3 cumulative revenue represents 76.7% of the ¥30.80bn forecast, versus a standard 75% progress rate. Operating income represents 80.2% of the ¥4.10bn forecast, 5.2 percentage points ahead of the standard pace. Ordinary income represents 81.0% of the ¥4.35bn forecast. Net income represents 84.2% of the ¥2.80bn forecast. No forecast-progress metric is more than 10 percentage points away from the standard seasonal benchmark. The forecast implies Q4 revenue of ¥7.18bn, operating income of ¥811m, and net income of ¥443m. Those implied Q4 profit requirements are below the Q1-Q3 cumulative quarterly average, providing an execution cushion, but sustaining the porous-material margin and improving fine-chemical profitability remain important.
Financial Health
Financial health is very strong. Current assets of ¥33.15bn exceeded current liabilities of ¥4.37bn by ¥28.79bn, producing working capital of ¥28.79bn. The current ratio was 759.1% and the quick ratio was 698.1%, far above conventional liquidity thresholds. Cash and deposits were ¥21.37bn, equivalent to 32.3% of total assets and nearly 4.9 times current liabilities. Total liabilities were ¥7.91bn against equity of ¥58.19bn, resulting in D/E of 0.14x. There is no warning on liquidity or leverage: the current ratio is well above 1.0 and D/E is far below 2.0. The capital structure therefore has no apparent short-term maturity mismatch, with current assets substantially exceeding short-term obligations. Interest expense was negligible at ¥0.2m, and interest coverage of 16,527.6x confirms minimal financing risk. Accounts receivable increased 26.1% YoY to ¥4.51bn, an increase of ¥935m, exceeding the 4.9% sales-growth rate. Electronically recorded monetary claims were ¥1.67bn, and the trade-receivables increase reflected in operating cash flow was ¥1.26bn. This receivables build should be monitored for collection timing and its effect on cash conversion. Inventories were reported at ¥2.66bn, while raw materials were ¥1.33bn and work in process was ¥465m; finished-goods exposure should be assessed alongside sales momentum. PPE was ¥23.46bn, or 35.5% of assets, with land accounting for ¥14.94bn; this is a meaningful but balance-sheet-supported fixed-asset base. Construction in progress of ¥1.32bn represents approximately 5.6% of PPE, indicating an active but not unusually large investment pipeline. Investment securities totaled ¥8.05bn, or 12.2% of assets, and introduce some market-value and realized-gain variability to earnings and equity. Defined-benefit liabilities of ¥1.47bn and directors' retirement provisions of ¥447m are manageable relative to equity but remain longer-term obligations.
Notable B/S Changes
Accounts receivable: +¥0.94bn (+26.1%) YoY to ¥4.51bn - growth materially exceeded the 4.9% sales increase and coincided with a ¥1.26bn trade-receivables operating-cash-flow outflow; collection timing and credit quality should be monitored. Construction in progress: +¥0.99bn YoY to ¥1.32bn - reflects a meaningful expansion of the manufacturing investment pipeline, increasing execution risk but potentially supporting future capacity or productivity. PPE: +¥0.80bn YoY to ¥23.46bn - fixed assets remain substantial at 35.5% of total assets, consistent with continuing capital investment. Cash and deposits: -¥0.88bn YoY to ¥21.37bn - cash declined as elevated ¥1.49bn CapEx, dividends, repurchases, and working-capital absorption exceeded operating cash generation, while liquidity remains very strong. Accumulated other comprehensive income: +¥0.28bn YoY to ¥0.96bn - primarily reflects securities valuation movements and adds sensitivity of equity to market-price changes.
Cash Flow Quality
Cash-flow quality is the key financial issue in the Q3 results. Operating cash flow was ¥1.55bn, only 0.66x net income of ¥2.36bn, below the 0.8x quality-alert threshold. This divergence is the direct root cause of the earnings-quality alert: accounting profit increased faster than cash generated from operations. Cash conversion was 0.38x of EBITDA, also below the 0.7x warning threshold and confirming weak conversion during the period. The principal observable working-capital driver was a ¥1.26bn increase in trade receivables in operating cash flow. Inventory also consumed ¥173m of operating cash flow. These movements are not, by themselves, evidence of manipulation, but receivables growth substantially above sales growth raises the importance of monitoring collection discipline and customer-credit quality. The accruals ratio was 1.2%, which is below the 5% high-quality benchmark and moderates the concern arising from the single-period OCF shortfall. Operating cash flow declined from ¥2.13bn in the prior-year period despite the ¥322m increase in net income, reinforcing that working-capital absorption was material. Capital expenditure rose 57.0% YoY to ¥1.49bn, or 6.3% of revenue, within a typical manufacturing investment range. CapEx/depreciation was 1.83x, indicating capacity expansion and/or accelerated replacement investment rather than underinvestment. Free cash flow was positive at ¥225m, but the small surplus means that internally generated cash after capital investment did not comfortably cover dividends and repurchases during the period. Investing cash flow was negative ¥1.33bn, including PPE purchases and net securities activity. Financing cash flow was negative ¥1.11bn, including ¥973m of cash dividends and ¥69m of share repurchases. Cash and cash equivalents decreased ¥882m to ¥21.13bn, but the remaining liquidity buffer is substantial.
Dividend Sustainability
The Q2 dividend was ¥23.50 per share, and the FY forecast dividend is ¥47.00 per share. The disclosed Q2-based payout ratio was 22.2%, which is low relative to net income and indicates that the ordinary dividend commitment is earnings-covered. The FY forecast DPS of ¥47.00 represents approximately 36.2% of forecast EPS of ¥129.66, remaining comfortably below the 60% sustainability benchmark. Cash dividends paid during the first nine months were ¥973m. Share repurchases were modest at ¥69m. Using dividends and repurchases together, capital returns should be assessed as a total return ratio rather than a dividend-only payout ratio. Free cash flow of ¥225m covered only 0.43x of the reported dividend requirement measure, reflecting the combination of weak operating cash conversion and elevated capital expenditure. This is a near-term cash-coverage constraint rather than a balance-sheet solvency issue, given the ¥21.37bn cash balance and low leverage. The FY dividend appears sustainable on forecast earnings and available liquidity. Sustained dividend growth would nevertheless depend on operating cash flow normalizing toward net income after receivable collection and on capital expenditure moderating or generating commensurate returns.
Risk Assessment
Business risks include Fine chemicals: revenue rose 2.4% but segment profit fell 14.3% to ¥1.30bn, compressing segment margin by about 241bp to 12.0%; a prolonged cost, pricing, or mix issue in the largest sales segment would weigh on consolidated profitability., Porous materials concentration: porous materials generated 45.0% of aggregate segment profit and drove most earnings growth; a reversal in its 19.7% margin or demand growth would have an outsized effect on consolidated earnings., Manufacturing execution: elevated CapEx of ¥1.49bn and construction in progress of ¥1.32bn create execution and return-on-investment risk if capacity additions or facility upgrades do not translate into volume or margin gains., Industry-specific chemical/manufacturing risk: input-cost volatility, product-quality obligations, environmental regulation, and changes in automotive/industrial demand can affect pricing, production costs, and utilization rates., Investment-income variability: ¥130m dividend income, ¥61m interest income, and a ¥189m gain on sales of investment securities contributed to earnings, exposing reported profit to portfolio income and market conditions..
Financial risks include Earnings-quality alert: OCF/net income of 0.66x is below 0.8x because operating cash flow of ¥1.55bn trailed net income of ¥2.36bn; the impact is reduced confidence that current-period earnings are immediately cash-realizable., Low-cash-conversion alert: OCF/EBITDA of 0.38x is below 0.7x; this constrains free cash flow despite a healthy 17.4% EBITDA margin and requires improvement in working-capital release., Receivables risk: accounts receivable increased 26.1% YoY to ¥4.51bn, while revenue rose only 4.9%; the effect has already appeared as a ¥1.26bn operating-cash-flow outflow., Capital-market exposure: investment securities of ¥8.05bn are 12.2% of assets, and security sales generated an extraordinary gain; portfolio valuation changes can affect OCI, realized gains, and capital allocation flexibility..
Key concerns include Highest priority: conversion of receivables into cash and restoration of OCF/net income toward or above 0.8x, given the direct impact on free cash flow., High priority: whether fine chemicals can restore its prior-year segment margin while preserving revenue growth., Medium priority: sustainability of the porous-material segment's strong 34.8% profit growth and 19.7% margin., Medium priority: realization of returns from CapEx running at 1.83x depreciation., Lower priority: the balance sheet has substantial resilience, with a 759.1% current ratio, 0.14x D/E, and negligible interest expense..
Investment Implications
Key takeaways include Sales, operating income, ordinary income, and net income all increased, with net income rising 15.8% YoY to ¥2.36bn., Margin performance improved at the consolidated level, with gross margin up 58bp to 38.4%, operating margin up 43bp to 13.9%, and net margin up 94bp to 10.0%., Porous materials is the core earnings contributor and the main source of growth, while fine chemicals is the principal profitability drag., The company has a highly liquid, low-leverage balance sheet that can absorb temporary free-cash-flow weakness and maintain shareholder distributions., Cash conversion, rather than reported profitability, is the principal issue: OCF/net income was 0.66x and OCF/EBITDA was 0.38x..
Metrics to watch include Operating cash flow, OCF/net income, and OCF/EBITDA., Trade receivables and electronic monetary claims relative to revenue growth., Fine-chemical revenue, segment profit, and segment margin., Porous-material sales growth and its 19.7% segment margin., Capital expenditure, construction-in-progress completion, and post-investment cash returns., Progress against FY forecasts of ¥30.80bn revenue, ¥4.10bn operating income, and ¥2.80bn net income., Realized and unrealized returns from the ¥8.05bn investment-securities portfolio..
Regarding relative positioning, The company combines above-average liquidity and conservative leverage with good operating and EBITDA margins, but its annualized 5.4% ROE is below the usual 8% threshold because of a large equity base and low asset turnover. Its near-term relative quality profile is therefore defined by strong solvency and improving margins on one hand, versus subpar cash conversion and a weakening profit contribution from the largest sales segment on the other.